Summary

Chile Radiotherapy Market Growth & Trends

The Chile radiotherapy market size is expected to reach USD 36.0 million by 2028, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2021 to 2028. The increasing prevalence of cancer and rising healthcare expenditure are factors expected to propel the growth over the forecast period.

There is a significant gap between the required and installed radiotherapy capacity in Chile. As per a recently published report in the International Journal of Radiation Oncology, Chile had around 41 operative LINACs, which is less than the number required to meet the demand. This provides significant opportunities for growth for the market.

According to the International Agency of Research on Cancer (IARC), the estimated number of new lung cancer cases in Chile was around 4,000 in 2020. The number is expected to reach around 5,500 by 2030. The rising incidence of lung cancer can be attributed to increasing smoking. As per the national health survey, currently, 32.5% of the people in Chile are active smokers. The rising incidence of cancer is expected to drive market growth.

Moreover, companies are adopting strategies that allow them to use their resources to aid in the development of new products and enhance their supply chain. For instance, in August 2020, Siemens Healthcare GmbH announced the acquisition of Varian Medical Systems, Inc. in an all-cash transaction that accounted for USD 16.4 billion. This acquisition may enable the company to offer end-to-end oncology products to address the unmet medical needs of cancer treatment on a global scale.

Chronic adverse effects of radiotherapy occur after months or years of treatment. These effects depend on the total dose of radiotherapy received and the area of treatment. In some regions of the body, radiation treatment can lead to a buildup of body fluids and can cause lymphedema. Radiation exposure to healthy cells in the body can lead to apoptosis, senescence, necrosis, and terminal differentiation of healthy cells, which can lead to death. Radiotherapy weakens the body and can attenuate a body's receptiveness to radiation therapy or surgery. The adverse effects of radiation therapy may restrain market growth.

Chile Radiotherapy Market Report Highlights

• In 2020, External Beam Radiation Therapy (EBRT) dominated the market and accounted for the largest revenue share of 86.5%. The high price and high installation base of EBRT equipment is one of the factors for the growth of the segment

• The internal beam radiation therapy segment is expected to witness a lucrative CAGR of 6.9% during the forecast period. The ability to deliver the precise dose, increased patient preference, and cost-effectiveness are some factors driving the segment

• The prostate cancer segment dominated the market and accounted for a share of 24.9% in the market in 2020 and is expected to continue its dominance throughout the forecast period. The high incidence and treatment rate of prostate cancer in Chile are some of the factors contributing to its dominance

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.7 Commodity Flow Analysis
1.7.1 Approach: Commodity Flow Approach
1.7.2 Approach 2: Country-wise market estimation using bottom-up approach
1.8 Global Market: CAGR Calculation
1.9 Research Assumptions
1.10 List of Secondary Sources
1.11 List of Abbreviations
1.12 Objectives
1.12.1 Objective 1
1.12.2 Objective 2
1.12.3 Objective 3
1.12.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Industry Outlook
3.1 SWOT Analysis; By Factor (Political & legal, economic, and technological)
3.2 Porter’s five forces analysis
3.3 Regulatory Landscape & Reimbursement Scenario
3.4 Market Variable Analysis
3.4.1 Rising adoption of radiotherapy
3.4.2 Technological advancements in radiotherapy
3.4.3 Rising prevalence of cancer
3.4.4 Increase in healthcare expenditure
3.5 Market Restraint & Challenges Analysis
3.5.1 Inadequate radiation infrastructure
3.5.2 Adverse effects of radiotherapy
3.6 Entry Barriers
3.7 Critical Success Factors
3.8 Major Deals and Strategic Alliances
3.8.1 New Product Launches
3.8.2 Mergers and Acquisitions
3.8.3 Research Collaborations
3.8.4 Conferences and Campaigns
Chapter 4 Chile Radiotherapy Market - Segment Analysis, By Type, 2016 - 2028 (USD Million)
4.1 Chile Radiotherapy Market: Type Movement Analysis
4.2 External Beam Radiotherapy
4.2.1 External Beam Radiotherapy Market, 2016 - 2028 (USD Million)
4.3 Internal Beam Radiotherapy
4.3.1 Internal Beam Radiotherapy Market, 2016 - 2028 (USD Million)
4.4 Systemic Radiotherapy
4.4.1 Systemic Radiotherapy Market, 2016 - 2028 (USD Million)
Chapter 5 Chile Radiotherapy Market - Segment Analysis, By Application, 2016 - 2028 (USD Million)
5.1 Chile Radiotherapy Market: Application Movement Analysis
5.2 Prostate cancer
5.2.1 Prostate cancer market, 2016 - 2028 (USD Million)
5.3 Breast cancer
5.3.1 Breast cancer market, 2016 - 2028 (USD Million)
5.4 Lung cancer
5.4.1 Lung cancer market, 2016 - 2028 (USD Million)
5.5 Head and neck cancer
5.5.1 Head and neck cancer market, 2016 - 2028 (USD Million)
5.6 Colorectal cancer
5.6.1 Colorectal cancer market, 2016 - 2028 (USD Million)
5.7 Others
5.7.1 Other Cancers market, 2016 - 2028 (USD Million)
Chapter 6 Chile Radiotherapy Market: Competitive Analysis
6.1 Recent Developments and Impact Analysis, by Key Market Participants
6.2 Vendor Landscape
6.2.1 List of key distributors and channel partners
6.2.2 Key company market share analysis, 2020
6.3 Public Companies
6.3.1 Company market position analysis
6.3.2 Competitive Dashboard Analysis
6.4 Private Companies
6.4.1 List of key emerging companies /technology disruptors/innovators
6.4.2 Regional network map
6.5 Company Profiles
6.5.1 Varian Medical Systems, Inc.
6.5.1.1 Company overview
6.5.1.2 Financial performance
6.5.1.3 Product benchmarking
6.5.1.4 Strategic initiatives
6.5.2 Elekta AB
6.5.2.1 Company overview
6.5.2.2 Financial performance
6.5.2.3 Product benchmarking
6.5.2.4 Strategic initiatives
6.5.3 Accuray Incorporated
6.5.3.1 Company overview
6.5.3.2 Financial performance
6.5.3.3 Product benchmarking
6.5.3.4 Strategic initiatives
6.5.4 Becton, Dickinson and Company
6.5.4.1 Company overview
6.5.4.2 Financial performance
6.5.4.3 Product benchmarking
6.5.4.4 Strategic initiatives
6.5.5 Isoray Medical
6.5.5.1 Company overview
6.5.5.2 Financial performance
6.5.5.3 Product benchmarking
6.5.5.4 Strategic initiatives
6.5.6 NTP Radioisotopes SOC Ltd.
6.5.6.1 Company overview
6.5.6.2 Financial performance
6.5.6.3 Product benchmarking
6.5.6.4 Strategic initiatives


List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of abbreviations
TABLE 3 List of key distributors
TABLE 4 List of key emerging companies /technology disruptors/innovators
TABLE 5 Chile radiotherapy market, by type, 2016 - 2028 (USD Million)
TABLE 6 Chile radiotherapy market, by application, 2016 - 2028 (USD Million)


List of Figures

FIG. 1 Chile radiotherapy market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Chile radiotherapy market snapshot
FIG. 10 SWOT analysis, by factor (political & legal economic and technological)
FIG. 11 Porter’s five forces analysis
FIG. 12 Chile radiotherapy market driver impact
FIG. 13 Chile radiotherapy market restraint impact
FIG. 14 Critical success factors
FIG. 15 Chile radiotherapy market: Type outlook and key takeaways
FIG. 16 Chile radiotherapy market: Type movement analysis
FIG. 17 External beam radiotherapy market, 2016 - 2028 (USD Million)
FIG. 18 Internal beam radiotherapy market, 2016 - 2028 (USD Million)
FIG. 19 Systemic radiotherapy market, 2016 - 2028 (USD Million)
FIG. 20 Chile radiotherapy market: Application outlook and key takeaways
FIG. 21 Chile radiotherapy market: Application movement analysis
FIG. 22 Prostate cancer market, 2016 - 2028 (USD Million)
FIG. 23 Breast cancer market, 2016 - 2028 (USD Million)
FIG. 24 Lung cancer market, 2016 - 2028 (USD Million)
FIG. 25 Head and neck cancer market, 2016 - 2028 (USD Million)
FIG. 26 Colorectal cancer market, 2016 - 2028 (USD Million)
FIG. 27 Other cancers market, 2016 - 2028 (USD Million)
FIG. 28 Recent developments and impact analysis, by key market participants
FIG. 29 Company market share analysis
FIG. 30 Company market position analysis
FIG. 31 Company market position analysis
FIG. 32 Competitive dashboard analysis
FIG. 33 Regional Network Map